eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | pancreatitis |
| Comorbidity | C0011860|type 2 diabetes mellitus |
| Sentences | 10 |
| PubMedID- 23300896 | Background: increased risks of acute pancreatitis in patients with type 2 diabetes mellitus have been reported recently in several countries. |
| PubMedID- 20371755 | Objective: to review the possible association between glucagon-like peptide-1 (glp-1) agonist use and pancreatitis in patients with type 2 diabetes mellitus. |
| PubMedID- 24736555 | Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. |
| PubMedID- 23269036 | Methods: all observational studies and randomized-controlled trials evaluating the relationship between type 2 diabetes mellitus and the risk of acute pancreatitis were identified in pubmed (january 1966), embase (january 1974), web of science (january 1986), and cochrane library, through march 2012. |
| PubMedID- 23440284 | Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. |
| PubMedID- 21577242 | Objectives: the objective of this study was to assess the risk of acute pancreatitis among patients with type 2 diabetes mellitus (dm) and identify the roles of co-morbidities and anti-diabetic drugs. |
| PubMedID- 24674587 | Prophylactic effects of the glucagon-like peptide-1 analog liraglutide on hyperglycemia in a rat model of type 2 diabetes mellitus associated with chronic pancreatitis and obesity. |
| PubMedID- 24859164 | Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study. |
| PubMedID- 20818118 | Case report: we report a case in which a woman with crohn's disease and type 2 diabetes mellitus developed recurrent episodes of acute pancreatitis due to extreme hypertriglyceridemia. |
| PubMedID- 21324812 | Conclusions: although incretin-based therapy effectively treats type 2 diabetes mellitus, emerging reports of acute pancreatitis in patients receiving sitagliptin and exenatide have prompted the us food and drug administration to issue an alert on these drugs. |
Page: 1